These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
532 related articles for article (PubMed ID: 21129042)
1. Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica. Solomon M; Pavlotsky F; Leshem E; Ephros M; Trau H; Schwartz E J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):973-7. PubMed ID: 21129042 [TBL] [Abstract][Full Text] [Related]
2. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis. Solomon M; Baum S; Barzilai A; Scope A; Trau H; Schwartz E J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541 [TBL] [Abstract][Full Text] [Related]
3. Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers. Solomon M; Pavlotzky F; Barzilai A; Schwartz E J Am Acad Dermatol; 2013 Feb; 68(2):284-9. PubMed ID: 22858005 [TBL] [Abstract][Full Text] [Related]
4. Leishmania tropica in northern Israel: a clinical overview of an emerging focus. Shani-Adir A; Kamil S; Rozenman D; Schwartz E; Ramon M; Zalman L; Nasereddin A; Jaffe CL; Ephros M J Am Acad Dermatol; 2005 Nov; 53(5):810-5. PubMed ID: 16243129 [TBL] [Abstract][Full Text] [Related]
5. Leishmania tropica in children: a retrospective study. Solomon M; Schwartz E; Pavlotsky F; Sakka N; Barzilai A; Greenberger S J Am Acad Dermatol; 2014 Aug; 71(2):271-7. PubMed ID: 24775403 [TBL] [Abstract][Full Text] [Related]
7. Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea. Guery R; Henry B; Martin-Blondel G; Rouzaud C; Cordoliani F; Harms G; Gangneux JP; Foulet F; Bourrat E; Baccard M; Morizot G; Consigny PH; Berry A; Blum J; Lortholary O; Buffet P; PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006094. PubMed ID: 29155816 [TBL] [Abstract][Full Text] [Related]
8. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis. Brown M; Noursadeghi M; Boyle J; Davidson RN Br J Dermatol; 2005 Jul; 153(1):203-5. PubMed ID: 16029352 [TBL] [Abstract][Full Text] [Related]
9. [CUTANEOUS LEISHMANIASIS IN ISRAEL 2016 - AN UPDATE]. Solomon M; Schwartz E Harefuah; 2016 Oct; 155(10):626-631. PubMed ID: 28530056 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India. Bumb RA; Mehta RD; Ghiya BC; Jakhar R; Prasad N; Soni P; Lezama-Davila C; Satoskar AR Br J Dermatol; 2010 Oct; 163(4):854-8. PubMed ID: 20500797 [TBL] [Abstract][Full Text] [Related]
11. Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica: preliminary findings of the study of 161 new cases from a new endemic focus in himachal pradesh, India. Sharma NL; Mahajan VK; Kanga A; Sood A; Katoch VM; Mauricio I; Singh CD; Parwan UC; Sharma VK; Sharma RC Am J Trop Med Hyg; 2005 Jun; 72(6):819-24. PubMed ID: 15964970 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Reithinger R; Mohsen M; Wahid M; Bismullah M; Quinnell RJ; Davies CR; Kolaczinski J; David JR Clin Infect Dis; 2005 Apr; 40(8):1148-55. PubMed ID: 15791515 [TBL] [Abstract][Full Text] [Related]
13. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate. Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486 [TBL] [Abstract][Full Text] [Related]
14. Rapidly progressing facial leishmaniasis: effective treatment with liposomal amphotericin B and a review of the management of Old World cutaneous leishmaniasis. Islam S Paediatr Int Child Health; 2018 May; 38(2):158-161. PubMed ID: 28281913 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment of childhood cutaneous leishmaniasis with liposomal amphotericin B: report of two cases. del Rosal T; Artigao FB; Miguel MJ; de Lucas R; del Castillo F J Trop Pediatr; 2010 Apr; 56(2):122-4. PubMed ID: 19656844 [TBL] [Abstract][Full Text] [Related]
16. Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran. Alborzi A; Pouladfar GR; Fakhar M; Motazedian MH; Hatam GR; Kadivar MR Am J Trop Med Hyg; 2008 Sep; 79(3):435-7. PubMed ID: 18784238 [TBL] [Abstract][Full Text] [Related]
17. A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience. Cascio A; di Martino L; Occorsio P; Giacchino R; Catania S; Gigliotti AR; Aiassa C; Iaria C; Giordano S; Colomba C; Polara VF; Titone L; Gradoni L; Gramiccia M; Antinori S J Antimicrob Chemother; 2004 Jul; 54(1):217-20. PubMed ID: 15150166 [TBL] [Abstract][Full Text] [Related]
18. Correlation of parasitic load with interleukin-4 response in patients with cutaneous leishmaniasis due to Leishmania tropica. Kumar R; Bumb RA; Salotra P FEMS Immunol Med Microbiol; 2009 Dec; 57(3):239-46. PubMed ID: 19799628 [TBL] [Abstract][Full Text] [Related]
19. Atypical mucocutaneous involvement with Leishmania donovani. Pulimood SA; Rupali P; Ajjampur SS; Thomas M; Mehrotra S; Sundar S Natl Med J India; 2012; 25(3):148-50. PubMed ID: 22963292 [TBL] [Abstract][Full Text] [Related]
20. Injectable paromomycin for Visceral leishmaniasis in India. Sundar S; Jha TK; Thakur CP; Sinha PK; Bhattacharya SK N Engl J Med; 2007 Jun; 356(25):2571-81. PubMed ID: 17582067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]